| | Application no. and date | 14842538.2 (espacenet)  (Federated)  (European Patent Register), 20140905 |  | Patent/reg. no. and date | DK/EP 3042669, 20230308 |  | Publication date | 20160713 |  | Priority no. and date | JP 2013184684, 20130906 |  | EP pub. no. and date | EP 3042669 20160713 |  | Effective date |  |  | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27 Kanda Nishiki-cho Chiyoda-ku,
 1018444 Tokyo , JP
 |  | Applicant ref. no. | PU278939DKQ |  | Inventor | OKABE, Hiroyuki, c/o TAIHO PHARMACEUTICAL CO., LTD. 3 Okubo
 Tsukuba-shi
 Ibaraki 300-2611, JP
 |  | Representative | Marks & Clerk LLP, 44, rue de la Vallée 
L-2661 Luxembourg, LU |  | Opponent |  |  | IPC Class | A61K 31/506 (2006.01) ,  A61K 31/513 (2006.01) ,  A61K 31/7072 (2006.01) ,  A61K 39/00 (2006.01) ,  A61K 39/395 (2006.01) ,  A61P 35/00 (2006.01) ,  A61P 43/00 (2006.01) ,  C07K 16/22 (2006.01) ,  C07K 16/28 (2006.01) |  | Title | ANTITUMORMIDDEL OG FORSTÆRKER AF ANTITUMORVIRKNING |  | Int. application no. | JP2014073436 |  | Int. publication no. | WO2015034032 |  | Related patent (certificate) | CA 2024 00004 |  | Status | DK/EP patent |  | Pædiatrisk forlængelse | - |  | Udløbsdato for pædiatrisk forlængelse | - | 
 |